Patent intelligence · GB
GB 2365868
Polynucleotides and polypeptides of the G-protein coupled receptor AXOR87
Polynucleotides and polypeptides of the G-protein coupled receptor AXOR87
Patent details — GB 2365868
- Jurisdiction
- GB
- Status
- expired
- Grant date
- Feb 27, 2002
- Expiration
- Feb 22, 2022
- Applicant
- SMITHKLINE BEECHAM CORP [US]
- CPC classes
- A61P 9/ 00 A I, A61P 25/ 16 A I, A61P 31/ 00 A I, A61P 37/ 00 A I
Quick answer
GB 2365868 (Polynucleotides and polypeptides of the G-protein coupled receptor AXOR87) is held by SMITHKLINE BEECHAM CORP [US]. Status: expired. Granted Feb 27, 2002. Expires Feb 22, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SMITHKLINE BEECHAM CORP [US]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61P 9/ 00 A I, A61P 25/ 16 A I, A61P 31/ 00 A I, A61P 37/ 00 A I, A61P/2516, A61P/3100
More from SMITHKLINE BEECHAM CORP [US]
Related pharmaceutical patents in our USPTO index.
-
SA 92120308
تركيبة للاستخدام الموضعي topical composition
expired -
AT E269330
CHEMISCHE VERBINDUNGEN
expired -
EP 1425277
HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG
expired -
SA 91110341
مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus
expired -
HU P0302480
PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
expired -
AT E245157
3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN
expired -
HK 1004528
Dentifrice compositions
expired -
HU P0204410
PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE
expired
Frequently asked questions
What is US patent 2365868?
GB 2365868 (Polynucleotides and polypeptides of the G-protein coupled receptor AXOR87) is held by SMITHKLINE BEECHAM CORP [US]. Status: expired. Granted Feb 27, 2002. Expires Feb 22, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns GB 2365868?
SMITHKLINE BEECHAM CORP [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does GB 2365868 expire?
Our index shows an expiration date of Feb 22, 2022 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.